Early abciximab administration in acute myocardial infarction treated with primary coronary intervention

International Journal of Cardiology

Volumn 108, Issue 1, 2006, Pages 36-42

  Bellandi, Francesco ^a   Maioli, Mauro ^a   Leoncini, Mario ^a   Toso, Anna ^a   Dabizzi, Roberto P ^a  

^a Prato Hospital   (Italy)

Author keywords

Angioplasty; Glicoproteins; Myocardial infarction; Scintigraphy; Stents

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; HEPARIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY RECANALIZATION; DRUG RESPONSE; ELECTROCARDIOGRAPHY; EMERGENCY WARD; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCINTIGRAPHY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; STENTS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 33644650062     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.04.025     Document Type: Article

References (34)

1. S.J. Brener, L.A. Barr, and J.E. Burchenal Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators Circulation 98 1998 734 741
2. F.J. Neumann, A. Kastrani, and C. Schmitt Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction J Am Coll Cardiol 35 2000 915 921
3. G.P. Montalescot for the ADMIRAL Investigators Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction N Engl J Med 344 2001 1895 1903
4. D. Antoniucci, A. Rodriguez, and A. Hempel A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction J Am Coll Cardiol 42 2003 1879 1885
5. The TIMI Study Group The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings N Engl J Med 312 1985 932 936
6. C.M. Gibson, C.P. Cannon, and W.L. Daley TIMI frame count: a quantitative method of assessing coronary artery flow Circulation 93 1996 879 888
7. A.W. van 't Hof, A. Liem, H. Suryapranata, J.C. Hoorntje, M.J. de Boer, and F. Zijlstra Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group Circulation 97 1998 2302 2306
8. A. Poli, R. Fetiveau, and P. Vandoni Integrated analysis of myocardial blush and ST-segment elevation recovery after successful primary angioplasty: real-time grading of microvascular reperfusion and prediction of early and late recovery of left ventricular function Circulation 106 2002 313 318
9. G. Germano, J. Erel, H. Lewin, P.B. Kavanagh, and D.S. Berman Automatic quantification of regional myocardial wall motion and thickening from gated technetium-99 m sestamibi myocardial perfusion single-photon emission computed tomography J Am Coll 30 1997 1360 1367
10. A. Schomig, A. Kastrati, and J. Dirschinger Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators N Engl J Med 343 2000 385 391
11. G.M. Santoro, R. Valenti, and P. Buonamici Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty Am J Cardiol 82 1998 932 937
12. The TIMI Study Group Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial N Engl J Med 320 1989 618 627
13. F.J. Neumann, R. Blasini, and C. Schmitt Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction Circulation 98 1998 2695 2701
14. G.W. Stone for the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
15. G. Montalescot, M. Borentain, L. Payot, J.P. Collet, and D. Thomas Early vs. late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis JAMA 292 2004 362 366
16. D.P. Lee, N.A. Herity, and B.L. Hiatt Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the Tirofiban Given in the Emergency Room before Primary Angioplasty (TIGER-PA) pilot trial Circulation 107 2003 1497 1501
17. A.W.J. Van't Hof, N. Ernst, and M.J. de Boer Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME trial) Eur Heart J 25 2004 837 846
18. M. Gyöngyösi for the ReoPro-BRIDGING Study Group Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion-results of the Austrian multi-centre randomized ReoPro-BRIDGING Study Eur Heart J 25 2004 2125 2133
19. W.B. Batchelor, T.R. Tolleson, and Y. Huang Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison of measurements of platelet aggregation with aggrastat, reopro, and eptifibatide Circulation 106 2002 1470 1476
20. G.W. Stone, D. Cox, and E. Garcia Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials Circulation 104 2001 636 641
21. C. Loubeyre, M.-C. Morice, and T. Lefevre A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction J Am Coll Cardiol 39 2002 15 21
22. G. Ndrepepa, J. Mehili, and M. Schwaiger Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction J Nucl Med 45 2004 725 729
23. H.K. Gold, H.D. Garabedian, and R.E. Dinsmore Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators: observations in animals and humans Circulation 95 1997 1755 1759
24. J.C. Reverter, S. Beguin, and H. Kessels Inhibition of platelet-medicated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody: potential implications for the effect of c7E3 Fab treatment on acute thrombosis and clinical restenosis J Clin Invest 98 1996 863 874
25. J.P. Collet, G. Montalescot, and C. Lesty Effects of abciximab on the architecture of platelet rich clots in patients with acute myocardial infarction undergoing primary coronary angioplasty Circulation 103 2001 2328 2331
26. L.F.M. van den Merkhof, F. Zijlstra, and H. Olsson Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty J Am Coll Cardiol 33 1999 1528 1532
27. E.M. Antman, R.P. Guigliano, and C.M. Gibson Abciximab facilitates the rate and extent of thrombolysis: results of the Thrombolysis in Myocardial Infarction (TIMI) 14 trial Circulation 99 1999 2720 2732
28. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group. The SPEED Group Trial of abciximab with and without low-dose reteplase for acute myocardial infarction Circulation 101 2000 2788 2794
29. S.G. Ellis, P. Armstrong, and A. Betriu Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial Am Heart J 147 2004 E16
30. E.J. Topol Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence Circulation 97 1998 211 218
31. M.T. Roe, E.M. Ohman, and A.C. Maas Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion J Am Coll Cardiol 37 2001 9 18
32. M. Gawaz, F.J. Neumann, and T. Dickfeld Vitronectin receptor (avb3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction Circulation 96 1997 1809 1818
33. D.I. Simon, H. Xu, S. Ortlepp, C. Rogers, and N.K. Rao 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1 Arterioscler Thromb Vasc Biol 17 1997 528 535
34. R.J. Gibbons, T.D. Miller, and T.F. Christian Infarct size measured by single photon emission computed tomographic imaging with (99 m)Tc-sestamibi: a measure of the efficacy of therapy in acute myocardial infarction Circulation 101 2000 101 108